Recurrent disability progression endpoints in multiple sclerosis clinical trials.

Saved in:
Bibliographic Details
Title: Recurrent disability progression endpoints in multiple sclerosis clinical trials.
Authors: Bühler A; University of Waterloo, Waterloo, ON, Canada., Wolbers M; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Model F; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Wang Q; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Belachew S; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Manfrini M; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Lorscheider J; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital, University of Basel, Basel, Switzerland., Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital, University of Basel, Basel, Switzerland., Beyersmann J; Ulm University, Ulm, Germany.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2023 Jan; Vol. 29 (1), pp. 130-139. Date of Electronic Publication: 2022 Sep 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36177953
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Recurrent disability progression endpoints in multiple sclerosis clinical trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bühler+A%22">Bühler A</searchLink>; University of Waterloo, Waterloo, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Wolbers+M%22">Wolbers M</searchLink>; F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Model+F%22">Model F</searchLink>; F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wang+Q%22">Wang Q</searchLink>; F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Belachew+S%22">Belachew S</searchLink>; F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Manfrini+M%22">Manfrini M</searchLink>; F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lorscheider+J%22">Lorscheider J</searchLink>; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kappos+L%22">Kappos L</searchLink>; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research and Biomedical Engineering, University Hospital, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Beyersmann+J%22">Beyersmann J</searchLink>; Ulm University, Ulm, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229509185%22">Multiple sclerosis (Houndmills, Basingstoke, England)</searchLink> [Mult Scler] 2023 Jan; Vol. 29 (1), pp. 130-139. <i>Date of Electronic Publication: </i>2022 Sep 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9509185 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213524585%22">13524585 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36177953
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/13524585221125382
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 130
    Titles:
      – TitleFull: Recurrent disability progression endpoints in multiple sclerosis clinical trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bühler A
      – PersonEntity:
          Name:
            NameFull: Wolbers M
      – PersonEntity:
          Name:
            NameFull: Model F
      – PersonEntity:
          Name:
            NameFull: Wang Q
      – PersonEntity:
          Name:
            NameFull: Belachew S
      – PersonEntity:
          Name:
            NameFull: Manfrini M
      – PersonEntity:
          Name:
            NameFull: Lorscheider J
      – PersonEntity:
          Name:
            NameFull: Kappos L
      – PersonEntity:
          Name:
            NameFull: Beyersmann J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2023 Jan
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1477-0970
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Multiple sclerosis (Houndmills, Basingstoke, England)
              Type: main
ResultId 1